Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes.

Clinical and Experimental Immunology
V A L HuurmanB O Roep

Abstract

An immunogenic peptide (p277) from the 60-kDa heat shock protein (hsp60) arrested beta-cell destruction in non-obese diabetic mice. A randomized, double-blind, phase Ib/II clinical trial of DiaPep277 peptide treatment was performed in recent-onset type 1 diabetes patients with remaining insulin production. We studied the immunological efficacy of this peptide therapy and correlated this with clinical outcome. Forty-eight C-peptide-positive patients were assigned subcutaneous injections of 0.2, 1.0 or 2.5 mg p277 (n = 12 per dosage) at entry, and 1, 6 and 12 months, or four placebo injections (n = 12). T cell autoimmunity to hsp60, DiaPep277, glutamic acid decarboxylase and tetanus toxoid (recall response control) were assayed by proliferation and cytokine secretion assays (enzyme-linked immunospot) at regular intervals until 18 months after the first injection. All treated patients at each dosage of peptide demonstrated an altered immune response to DiaPep277, while the majority of placebo-treated patients remained non-responsive to treatment (P = 0.00001), indicating a 100% efficacy of immunization. Cytokine production in response to therapy was dominated by interleukin (IL)-10. IL-10 production before therapy and decreasing a...Continue Reading

References

Sep 8, 1988·The New England Journal of Medicine·J SilversteinS Johnson
Jan 15, 1983·British Medical Journal·J LudvigssonA Lernmark
Mar 19, 1994·Lancet·D Elias, I R Cohen
Mar 14, 1998·Journal of Autoimmunity·V AblamunitsI R Cohen
Nov 24, 1999·The Journal of Clinical Investigation·M PeakmanR M Chicz
Jul 31, 2001·Lancet·M A Atkinson, G S Eisenbarth
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Nov 18, 2003·Tissue Antigens·S M Lieberman, T P DiLorenzo
Feb 3, 2004·The Journal of Clinical Investigation·Sefina ArifMark Peakman
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Jun 13, 2006·The Journal of Clinical Investigation·Alexandra Zanin-ZhorovIrun R Cohen
Aug 16, 2006·Clinical and Experimental Immunology·B Z AlizadehUNKNOWN DIABMARKER Study Group
Oct 7, 2006·Diabetes/metabolism Research and Reviews·Volkert A L HuurmanBart O Roep
Mar 14, 2007·Clinical and Experimental Immunology·T Staeva-VieiraM von Herrath

❮ Previous
Next ❯

Citations

Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Jul 26, 2011·Clinical & Developmental Immunology·Brett PhillipsNick Giannoukakis
Jun 13, 2009·Arthritis Research & Therapy·Yvonne VercoulenBerent J Prakken
Dec 25, 2008·PloS One·Francisco J QuintanaIrun R Cohen
Jan 1, 2012·The Review of Diabetic Studies : RDS·F Susan Wong, Li Wen
Jan 1, 2012·The Review of Diabetic Studies : RDS·Ken T CoppietersMatthias G von Herrath
Mar 15, 2011·Immunotherapy·Alba E Morales, Kathryn M Thrailkill
Nov 5, 2009·Clinical Medicine : Journal of the Royal College of Physicians of London·Paul Grant, David Lipscomb
Mar 16, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ken T CoppietersMatthias G von Herrath
Mar 21, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Roberto Mallone, Bart O Roep
Oct 5, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Nanette C Schloot, Irun R Cohen
Jan 16, 2014·Cell Stress & Chaperones·Huib de JongBerent J Prakken
Aug 5, 2014·Clinical Reviews in Allergy & Immunology·Tingting TanZhiguang Zhou
Dec 26, 2009·Expert Opinion on Biological Therapy·Britta FischerThomas Linn
Sep 15, 2015·Expert Opinion on Investigational Drugs·Ian C DavisStephen N Davis
Jan 23, 2016·Frontiers in Immunology·Minh N PhamJose Luis Vela
Jun 14, 2013·Autoimmune Diseases·Kamal D MoudgilYehuda Shoenfeld
Dec 10, 2015·Drugs·Johnny Ludvigsson
Nov 19, 2015·Cell Stress & Chaperones·Cecilia Wick
Sep 2, 2009·Diabetes·Jide Tian, Daniel L Kaufman
Aug 2, 2016·Journal of Diabetes Research·Joshua Juwono, Ryan D Martinus
Jun 26, 2012·Journal of Autoimmunity·Nicolas SchallSylviane Muller
Dec 15, 2010·Trends in Immunology·Francisco J Quintana, Irun R Cohen
Jan 29, 2014·Nature Reviews. Endocrinology·Bart O Roep, Timothy I M Tree
Apr 12, 2012·Diabetes/metabolism Research and Reviews·A A Verrijn StuartB J Prakken
Aug 13, 2009·European Journal of Immunology·Matthias von Herrath, Gerald T Nepom
Jun 16, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·J Smith-PalmerS R Pillemer
Jan 26, 2010·Nature Reviews. Immunology·Bart O Roep, Mark Peakman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.